- Home
- TGI vs ARWR Comparison
TGI vs ARWR Comparison
Compare TGI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGI
- ARWR
- Stock Information
- Founded
- TGI 1993
- ARWR 2003
- Country
- TGI United States
- ARWR United States
- Employees
- TGI N/A
- ARWR N/A
- Industry
- TGI Aerospace
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- TGI Industrials
- ARWR Health Care
- Exchange
- TGI Nasdaq
- ARWR Nasdaq
- Market Cap
- TGI 2.0B
- ARWR 1.8B
- IPO Year
- TGI 1996
- ARWR 1993
- Fundamental
- Price
- TGI $25.85
- ARWR $15.32
- Analyst Decision
- TGI Hold
- ARWR Buy
- Analyst Count
- TGI 8
- ARWR 8
- Target Price
- TGI $20.63
- ARWR $43.71
- AVG Volume (30 Days)
- TGI 1.5M
- ARWR 1.5M
- Earning Date
- TGI 08-06-2025
- ARWR 08-07-2025
- Dividend Yield
- TGI N/A
- ARWR N/A
- EPS Growth
- TGI N/A
- ARWR N/A
- EPS
- TGI 0.52
- ARWR N/A
- Revenue
- TGI $1,261,962,000.00
- ARWR $545,209,000.00
- Revenue This Year
- TGI $9.20
- ARWR $21,924.50
- Revenue Next Year
- TGI $6.89
- ARWR N/A
- P/E Ratio
- TGI $49.18
- ARWR N/A
- Revenue Growth
- TGI 5.87
- ARWR 1436.97
- 52 Week Low
- TGI $11.01
- ARWR $9.57
- 52 Week High
- TGI $25.96
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- TGI 59.55
- ARWR 46.47
- Support Level
- TGI $25.70
- ARWR $15.19
- Resistance Level
- TGI $25.88
- ARWR $16.06
- Average True Range (ATR)
- TGI 0.08
- ARWR 0.68
- MACD
- TGI -0.02
- ARWR -0.23
- Stochastic Oscillator
- TGI 57.69
- ARWR 15.23
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.